BioSpace News Archive

Oragenics, Inc. Announces Reverse Stock Split Effective January 19, 2018

The Company’s common stock will begin trading on a split-adjusted basis when the markets open on January 22, 2018 under the existing trading symbol “OGEN”.

January 8, 2018
·
4 min read
Business

IDEXX to Introduce Applied BioCode’s Innovative Multiplex Technology Across Global Reference Laboratory Network

IDEXX and Applied BioCode today announced that they have entered into an exclusive global agreement to bring Applied BioCode’s digital multiplex platform to IDEXX Reference Laboratories customers.

January 8, 2018
·
4 min read
Business

Nevro Announces Preliminary Unaudited Fourth Quarter and Fiscal Year 2017 Revenue

The company announced that preliminary unaudited fourth quarter worldwide revenue is expected to be in the range of $97.4 to $97.9M.

January 8, 2018
·
3 min read
Biotech Beach

SoCal’s Neural Analytics Banks $15M

Neural Analytics announced that it has raised $15 million in Series B financing led by Alpha Edison.

January 8, 2018
·
3 min read
Drug Development

Ramaswamy’s Axovant Abandons Intepirdine After Dementia Trial Fails

Intepirdine did not meet its primary efficacy endpoints in the Phase 2b HEADWAY and pilot Phase 2 Gait and Balance studies.

January 8, 2018
·
11 min read
Business

Genomics England Adopts Edico Genome’s DRAGEN Bio-IT Platform to Increase Accuracy, Consistency of Next-Generation Sequencing Analysis

Today at the annual J.P. Morgan Healthcare Conference, Edico Genome and Genomics England announced a new partnership to strengthen the accuracy and consistency of NGS data analysis in Genomics England’s Rare Disease Pilot.

January 8, 2018
·
3 min read
Business

Eiger BioPharma Announces Appointment of Commercial Operations Industry Veteran Eldon Mayer to its Board of Directors

Eiger BioPharma announced today the appointment of Eldon Mayer to its Board of Directors.

January 8, 2018
·
3 min read
Business

Alcyone Lifesciences Announces Research Collaboration With a Leading Biopharmaceutical Company to Improve Intrathecal Delivery of Therapies for Rare and Orphan Neurological Conditions

Alcyone’s proprietary Pulsar advanced precision CNS delivery platform utilizes the cerebrospinal fluid dynamics to precision deliver and optimally biodistribute therapeutics to targets of interest in the CNS.

January 8, 2018
·
2 min read
Biotech Beach

Heron Therapeutics Highlights Progress in CINV and Pain Management Franchises

Heron today highlighted progress in the Company’s pain management and CINV franchises.

January 8, 2018
·
7 min read
Deals

Covance Introduces Dedicated Offering Designed for Biotech, Medical Device and Diagnostics Companies

This unique offering follows the acquisition of Chiltern, a leading contract research organization with a track record of engagement models that meet the specific needs of these client segments.

January 8, 2018
·
3 min read